FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
Executive Summary
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall